A Detroit Free Press op-ed by Drs. Kirstin Woody Scott and A. Mark Fendrick, MD, Director of the Center for Value-Based Insurance Design, discusses current legislation efforts to cap out-of-pocket insulin costs. Such policies could also spur broader systemic changes to ensure that insulin remains affordable for all stakeholders and for those whose lives depend on it.